Schedule 13D ownership disclosure

CYCLACEL PHARMACEUTICALS INC

Common Stock, $0.001 par value · CUSIP: 23254L801

Event date: 2025-08-05

Filing-level shares
0.00
Percent of class
0%
  • Lazar David E.Reported CIK 0001932843

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002135
Form type
SCHEDULE 13D/A
Filer
Bio Green Med Solution, Inc.
CIK
CIK 1130166
Filed
Aug 08, 2025
Reporting period
Aug 05, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub